Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$537M |
| 2 |
Peloton Interactive
PTON
|
+$373M |
| 3 |
Amazon
AMZN
|
+$306M |
| 4 |
S&P Global
SPGI
|
+$244M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$1.27B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$744M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$712M |
| 5 |
Pinduoduo
PDD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 16.67% |
| 3 | Consumer Discretionary | 11.17% |
| 4 | Communication Services | 10.86% |
| 5 | Consumer Staples | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVLP
1701
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $4.22M | ﹤0.01% |
1,023,207
+29,000
| +3% | +$167K |
|
|
OMCC
1702
DELISTED
Old Market Capital Corp
OMCC
| $4.2M | ﹤0.01% |
501,350
+8,607
| +2% | +$67.6K |
|
1703
Neuronetics
STIM
$164M
| $4.2M | ﹤0.01% |
377,961
-48,600
| -11% | -$365K |
|
1704
First Business Financial Services
FBIZ
$601M
| $4.2M | ﹤0.01% |
227,965
+8,300
| +4% | +$150K |
|
1705
Everest Group
EG
$14.3B
| $4.19M | ﹤0.01% |
17,900
-55,900
| -76% | -$12.3M |
|
1706
Bankwell Financial Group
BWFG
$536M
| $4.17M | ﹤0.01% |
213,500
+19,200
| +10% | +$334K |
|
1707
DLH Holdings
DLHC
$70.1M
| $4.16M | ﹤0.01% |
446,268
-16,062
| -3% | -$151K |
|
|
AGTC
1708
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $4.16M | ﹤0.01% |
1,016,840
-52,800
| -5% | -$259K |
|
|
TPTX
1709
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.16M | ﹤0.01% |
34,100
-63,000
| -65% | -$6.9M |
|
|
ABB
1710
DELISTED
ABB Ltd
ABB
| $4.15M | ﹤0.01% |
148,500
-120,800
| -45% | -$3.22M |
|
1711
SIGA Technologies
SIGA
$226M
| $4.14M | ﹤0.01% |
569,314
-6,500
| -1% | -$45.8K |
|
1712
Franklin Electric
FELE
$4.87B
| $4.12M | ﹤0.01% |
59,500
+7,100
| +14% | +$468K |
|
1713
Essent Group
ESNT
$6.13B
| $4.11M | ﹤0.01% |
95,190
-9,910
| -9% | -$428K |
|
1714
VanEck Semiconductor ETF
SMH
$71.6B
| $4.11M | ﹤0.01% |
+37,600
| New | +$3.73M |
|
1715
Equity Residential
EQR
$25.4B
| $4.1M | ﹤0.01% |
69,200
-1,371,900
| -95% | -$77.5M |
|
1716
iShares Silver Trust
SLV
$29.9B
| $4.1M | ﹤0.01% |
166,700
-251,700
| -60% | -$5.72M |
|
|
CCXI
1717
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.09M | ﹤0.01% |
+66,100
| New | +$3.78M |
|
1718
Equity Bancshares
EQBK
$1.06B
| $4.09M | ﹤0.01% |
189,500
+8,400
| +5% | +$163K |
|
1719
iShares MSCI Japan ETF
EWJ
$22.5B
| $4.07M | ﹤0.01% |
+60,300
| New | +$3.79M |
|
1720
Orion Group Holdings
ORN
$418M
| $4.06M | ﹤0.01% |
819,363
+70,166
| +9% | +$272K |
|
1721
Akebia Therapeutics
AKBA
$346M
| $4.05M | ﹤0.01% |
1,447,927
+1,377,752
| +1,963% | +$4.02M |
|
1722
Reading International Class A
RDI
$34.1M
| $4.04M | ﹤0.01% |
805,690
-18,400
| -2% | -$64.2K |
|
1723
Mesa Laboratories
MLAB
$574M
| $4.04M | ﹤0.01% |
14,100
-28,000
| -67% | -$7.7M |
|
1724
ICU Medical
ICUI
$4.16B
| $4.03M | ﹤0.01% |
18,800
-25,000
| -57% | -$4.85M |
|
1725
Tenet Healthcare
THC
$21.1B
| $4.03M | ﹤0.01% |
100,975
+79,200
| +364% | +$2.56M |
|
Similar funds
Renaissance Technologies's Q4 2020 Portfolio in Review
As of Q4 2020, Renaissance Technologies held 3,901 positions worth $92.1B, down 8% from $100B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies withdrew a net $21.6B in Q4 2020, closing 555 positions and reducing 1,622 holdings. Its most notable exit was Charter Communications, an estimated $341M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in NVIDIA worth $524M.
- Renaissance Technologies's largest Q4 2020 buy was NVIDIA: 40,123,720 shares worth $524M.
- Renaissance Technologies added most to Amazon in Q4 2020, an estimated $306M increase.
- Renaissance Technologies's biggest Q4 2020 reduction was Zoom, cutting an estimated $1.27B.
- Renaissance Technologies fully exited Charter Communications in Q4 2020, selling an estimated $341M.
- Renaissance Technologies's ten largest holdings make up 13% of its $92.1B portfolio in Q4 2020.
- Renaissance Technologies opened 565 new positions and closed 555 in Q4 2020.
- Renaissance Technologies's portfolio value fell 8% quarter-over-quarter to $92.1B.
Based on Renaissance Technologies's 13F filing for Q4 2020, filed 10 Feb 2021.